We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Vitamin D Slashes Cancer Risk

By Biotechdaily staff writers
Posted on 18 Jan 2006
An extensive systematic review of scientific literature has shown that taking 1,000 international units of vitamin D3 daily may reduce a person's cancer risk by as much as 50%.

Investigators at the University of California, San Diego (USA) evaluated 63 studies on the relationship between vitamin D and cancer that had been published between 1966 and 2004. More...
The studies included 30 on colon cancer, 13 on breast cancer, 26 on prostate cancer, and seven on ovarian cancer. Some of the studies touched on more than one type of cancer.

Analysis of the results was published in the December 27, 2005, online edition of the American Journal of Public Health. The majority of studies found a protective relationship between sufficient vitamin D status and lower risk of cancer. Based on their findings, the authors recommended a daily intake of 1,000 IU/day of vitamin D, half the safe upper intake established by the [U.S] National Academy of Sciences. The vitamin should be from the diet, food supplements, and a minimal exposure to sunlight (no more than 15 minutes of exposure daily over 40% of the body, other than the face, which should be protected from the sun).

"A preponderance of evidence, from the best observational studies the medical world has to offer, gathered over 25 years, has led to the conclusion that public health action is needed,” said first author Dr. Cedric F. Garland, professor of medicine at the University of California, San Diego. "Primary prevention of these cancers has largely been neglected, but we now have proof that the incidence of colon, breast, and ovarian cancer can be reduced dramatically by increasing the public's intake of vitamin D.”




Related Links:
University of California, San Diego

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.